MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

Molecular Pharmacology Fast Forward
First published on August 24, 2005; DOI: 10.1124/mol.105.017459

0026-895X/05/6805-1431-1438$20.00
Mol Pharmacol 68:1431-1438, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.017459v1
68/5/1431    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lansdell, S. J.
Right arrow Articles by Millar, N. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lansdell, S. J.
Right arrow Articles by Millar, N. S.

RIC-3 Enhances Functional Expression of Multiple Nicotinic Acetylcholine Receptor Subtypes in Mammalian Cells

Stuart J. Lansdell, Veronica J. Gee, Patricia C. Harkness, Anne I. Doward, Elizabeth R. Baker, Alasdair J. Gibb, and Neil S. Millar

Department of Pharmacology, University College London, London, United Kingdom

Recent studies have shown that RIC-3, originally identified in Caenorhabditis elegans as the protein encoded by the gene resistance to inhibitors of cholinesterase (ric-3), can enhance functional expression of {alpha}7 nicotinic acetylcholine receptors (nAChRs). In the present study, the influence of C. elegans and human RIC-3 upon multiple homomeric ({alpha}7, {alpha}8, and {alpha}9) and heteromeric ({alpha}3{beta}2, {alpha}3{beta}4, {alpha}4{beta}2, {alpha}4{beta}4, and {alpha}9{alpha}10) nAChR subtypes has been examined in transfected mammalian cells by radioligand binding and functional characterization. Coexpression of RIC-3 facilitates a dramatic enhancement of the ability of {alpha}7 (and the closely related {alpha}8 subunit) to generate functional nAChRs in otherwise nonpermissive mammalian cells. In contrast, coexpression of RIC-3 did not facilitate functional expression of either homomeric {alpha}9 or heteromeric {alpha}9{alpha}10 nAChRs in mammalian cell lines. It is noteworthy that whereas RIC-3 has been reported to cause a marked functional inhibition of heteromeric nAChRs such as {alpha}3{beta}4 and {alpha}4{beta}2 expressed in Xenopus laevis oocytes, RIC-3 significantly enhances levels of functional expression of these and other ({alpha}3{beta}2 and {alpha}4{beta}4) heteromeric nAChRs when expressed in mammalian cell lines. In addition, the interaction of multiple nAChR subunits ({alpha}3, {alpha}4, {alpha}7, {beta}2, and {beta}4) with RIC-3 has been demonstrated by coimmunoprecipitation from metabolically labeled transfected cells. It is significant that coimmunoprecipitation experiments have provided evidence that RIC-3 associates with unassembled nAChR subunits, a finding that is consistent with previous suggestions that RIC-3 may act by enhancing the maturation (subunit folding and assembly) of nAChRs. We conclude that RIC-3 is an nAChR-associated protein that can enhance functional expression of multiple nAChR subtypes in transfected mammalian cells.

Received July 29, 2005; accepted August 24, 2005

Address correspondence to: Dr. Neil Millar, Department of Pharmacology, University College London, Gower St., London, WC1E 6BT United Kingdom. E-mail: n.millar{at}ucl.ac.uk




This article has been cited by other articles:


Home page
 J. Neurosci.Home page
K. Rezvani, Y. Teng, Y. Pan, J. A. Dani, J. Lindstrom, E. A. Garcia Gras, J. M. McIntosh, and M. De Biasi
UBXD4, a UBX-Containing Protein, Regulates the Cell Surface Number and Stability of {alpha}3-Containing Nicotinic Acetylcholine Receptors
J. Neurosci., May 27, 2009; 29(21): 6883 - 6896.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
Y. Biala, J. F. Liewald, H. C. Ben-Ami, A. Gottschalk, and M. Treinin
The Conserved RIC-3 Coiled-Coil Domain Mediates Receptor-specific Interactions with Nicotinic Acetylcholine Receptors
Mol. Biol. Cell, March 1, 2009; 20(5): 1419 - 1427.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
E. X. Albuquerque, E. F. R. Pereira, M. Alkondon, and S. W. Rogers
Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
Physiol Rev, January 1, 2009; 89(1): 73 - 120.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
A. Kuryatov, J. Onksen, and J. Lindstrom
Roles of Accessory Subunits in {alpha}4{beta}2* Nicotinic Receptors
Mol. Pharmacol., July 1, 2008; 74(1): 132 - 143.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Cheng, K. A. Bollan, S. M. Greenwood, A. J. Irving, and C. N. Connolly
Differential Subcellular Localization of RIC-3 Isoforms and Their Role in Determining 5-HT3 Receptor Composition
J. Biol. Chem., September 7, 2007; 282(36): 26158 - 26166.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Razani-Boroujerdi, R. T. Boyd, M. I. Davila-Garcia, J. S. Nandi, N. C. Mishra, S. P. Singh, J. C. Pena-Philippides, R. Langley, and M. L. Sopori
T Cells Express {alpha}7-Nicotinic Acetylcholine Receptor Subunits That Require a Functional TCR and Leukocyte-Specific Protein Tyrosine Kinase for Nicotine-Induced Ca2+ Response
J. Immunol., September 1, 2007; 179(5): 2889 - 2898.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
P. Tumkosit, A. Kuryatov, J. Luo, and J. Lindstrom
beta3 Subunits Promote Expression and Nicotine-Induced Up-Regulation of Human Nicotinic {alpha}6* Nicotinic Acetylcholine Receptors Expressed in Transfected Cell Lines
Mol. Pharmacol., October 1, 2006; 70(4): 1358 - 1368.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics